CNA FINANCIAL CORP
For the period ended Dec 31, 2023. Filed Feb 6, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 6, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Life & Group
The Life & Group segment includes our run-off long-term care business as well as structured settlement obligations not funded by annuities related to certain property and casualty claimants. Long-term care policies were sold on both an individual and group basis.
The following table summarizes the results of operations for Life & Group.
| (In millions) | 2023 | 2022 (1) | 2021 (1) | ||
|---|---|---|---|---|---|
| Net earned premiums | $451 | $473 | $491 | ||
| Claims, benefits and expenses | 1,436 | 1,596 | 1,374 | ||
| Net investment income | 896 | 804 | 966 | ||
| Core (loss) income | (48) | (221) | 108 |
(1) As of January 1, 2023, we adopted ASU 2018-12 using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts presented in the financial statements have been adjusted to reflect application of the new guidance. See Note A and Note F to the Consolidated Financial Statements for additional information.
Core loss decreased $173 million in 2023 as compared with 2022 primarily due to higher net investment income and an unfavorable pretax impact of $181 million in the prior year as a result of the annual reserve reviews, partially offset by long-term care policy buyouts in 2023. Policy buyouts generally result in an unfavorable impact on core loss, as the cash payments are linked to higher statutory reserve levels. Excluding the impacts of long-term care policy buyouts, 2023 underwriting results are generally in line with reserving expectations.
Both years are inclusive of cash flow assumption updates as a result of the annual reserve review completed in the third quarter of each year. Cash flow assumption updates for 2023 resulted in an $8 million pretax increase in long-term care reserves. Adjusted to reflect the application of the LDTI accounting standard, the cash flow assumption updates for 2022 resulted in a $186 million pretax increase in long-term care reserves, primarily driven by the unfavorable impact of increased cost of care inflation, partially offset by favorable premium rate assumptions.
The annual structured settlement review resulted in a pretax reduction in claim reserves of $6 million and $5 million for 2023 and 2022.
Results for both years have been adjusted to reflect the application of the LDTI accounting standard.
Core results decreased $329 million in 2022 as compared with 2021 primarily due to the unfavorable impact of the 2022 annual reserve reviews and lower net investment income.
Cash flow assumption updates, as a result of the annual reserve reviews, for 2022 resulted in an $186 million pretax increase in long-term care reserves compared to a $3 million pretax increase in 2021.
The annual structured settlement review resulted in a pretax reduction in claim reserves of $5 million for 2022 and a pretax increase to claim reserves of $2 million for 2021.
The following tables summarize policyholder reserves for Life & Group.
| (In millions) | Claim and claim adjustment expenses | Future policy benefits | Total |
|---|---|---|---|
| Long-term care | $— | $13,959 | $13,959 |
| Structured settlement annuities and other | 582 | — | 582 |
| Total | 582 | 13,959 | 14,541 |
| Ceded reserves | 93 | — | 93 |
| Total gross reserves | $675 | $13,959 | $14,634 |
| (In millions) | Claim and claim adjustment expenses | Future policy benefits | Total |
|---|---|---|---|
| Long-term care (1) (2) | $— | $13,480 | $13,480 |
| Structured settlement annuities and other | 594 | — | 594 |
| Total | 594 | 13,480 | 14,074 |
| Ceded reserves | 101 | — | 101 |
| Total gross reserves | $695 | $13,480 | $14,175 |
(1) As of January 1, 2023, we adopted ASU 2018-12 using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts presented in the financial statements have been adjusted to reflect application of the new guidance. See Note A and Note F to the Consolidated Financial Statements for additional information.
(2) In conjunction with the adoption of ASU 2018-12, at January 1, 2023 we reclassified the long-term care reserves for policyholders currently receiving benefits from Claim and claim adjustment expense to Future policy benefits. This change was applied retrospectively as of January 1, 2021.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.